Viewing Study NCT05990920


Ignite Creation Date: 2025-12-25 @ 4:28 AM
Ignite Modification Date: 2025-12-26 @ 3:32 AM
Study NCT ID: NCT05990920
Status: COMPLETED
Last Update Posted: 2024-11-20
First Post: 2023-07-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy
Sponsor: NKGen Biotech, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module